Eosinophilic Esophagitis: A rapidly emerging disorder

Swiss Medical Weekly

Volumn 142, Issue FEBRUARY, 2012, Pages

  Straumann, Alex ^a,b  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b Chairman Swiss EoE Research Group   (Switzerland)

Author keywords

Clinical manifestation; Endoscopy; Eosinophilic esophagitis; Histopathology; Treatment

Indexed keywords

CORTICOSTEROID; MEPOLIZUMAB; PROTON PUMP INHIBITOR; GLUCOCORTICOID;

CLINICAL FEATURE; DRUG EFFICACY; EOSINOPHILIC ESOPHAGITIS; EOSINOPHILIC GASTRITIS; ESOPHAGUS STRICTURE; GASTROESOPHAGEAL REFLUX; HUMAN; LOW DRUG DOSE; NOTE; OROPHARYNX CANDIDIASIS; SYMPTOM; THERAPY EFFECT; ANIMAL; BALLOON DILATATION; BIOPSY; DIFFERENTIAL DIAGNOSIS; ESOPHAGUS; GASTROINTESTINAL ENDOSCOPY; HEALTH; METHODOLOGY; MORBIDITY; PATHOLOGY; PROGNOSIS; PROTEIN RESTRICTION; REVIEW;

ANIMALS; BALLOON DILATION; BIOPSY; DIAGNOSIS, DIFFERENTIAL; DIET, PROTEIN-RESTRICTED; ENDOSCOPY, GASTROINTESTINAL; EOSINOPHILIC ESOPHAGITIS; ESOPHAGUS; GLUCOCORTICOIDS; HUMANS; MORBIDITY; PROGNOSIS; PROTON PUMP INHIBITORS; WORLD HEALTH;

EID: 84858257955     PISSN: 14247860     EISSN: None     Source Type: Journal    
DOI: 10.4414/smw.2012.13513     Document Type: Note

References (42)

1. Attwood SE, Smyrk TC, Demeester TR, Jones JB. Esophageal eosinophilia with dysphagia, a distinct clinicopathologic syndrome. Dig Dis Sci. 1993;38:109-16. (Pubitemid 23039460)
2. Straumann A, Spichtin HP, Bernoulli R, Loosli J, Vögtlin J. Idiopathic eosinophilic esophagitis: a frequently overlooked disease with typical clinical aspects and discrete endoscopic findings [in German with English abstract]. Schweiz Med Wochenschr. 1994;124:1419-29. (Pubitemid 24267319)
3. Kelly KJ, Lazenby AJ, Rowe PC, Yardley JH, Perman JA, Sampson HA. Eosinophilic esophagitis attributed to gastroesophageal reflux: improvement with an amino acid-based formula. Gastroenterology. 1995;109:1503-12.
4. Furuta GT, Liacouras C, Collins MH, Gupta S, Justinich C, Putnam P, et al. Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology. 2007;133:1342-63.
5. Liacouras CA, Furuta GT, Hirano I, Atkins D, Attwood SE, Bonis PA, et al. Eosinophilic esophagitis: Updated consensus recommendations for children and adults. J Allergy Clin Immunol. 2011;128:3-20.
6. Kapel RC, Miller JK, Torres C, Aksoy S, Lash R, Katzka DA. Eosinophilic esophagitis: A prevalent disease in the United States that affects all age groups. Gastroenterology. 2008;134:1316-21. (Pubitemid 351615360)
7. Prasad GA, Alexander JA, Schleck CD, Zinsmeister AR, Smyrk TC, Elias RM, et al. Epidemiology of eosinophilic esophagitis over three decades in Olmsted County, Minnesota. Clin Gastroenterol Hepatol. 2009;7:1055-61.
8. Hruz P, Straumann A, Bussmann C, Heer P, Simon HU, Zwahlen M, et al. Escalating incidence of eosinophilic esophagitis: A 20 year prospective, population-based study in Olten County Switzerland. J Allergy Clin Immunol. 2011;128:1349-50.
9. Noel RJ, Putnam PE, Rothenberg ME. Eosinophilic esophagitis. N Engl J Med. 2004;351:940-1.
10. Straumann A, Bussmann C, Zuber M, Vannini S, Simon HU, Schoepfer AM. Eosinophilic Esophagitis: Analysis of food impaction and perforation in 251 adolescent and adult patients. Clin Gastroenterol Hepatol. 2008;6:598-600.
11. Varadarajulu S, Eloubeidi MA, Patel RS, Mulcahy HE, Barkun A, Jowell P, et al. The yield and the predictors of esophageal pathology when upper endoscopy is used for the initial evaluation of dysphagia. Gastrointest Endosc. 2005;61;804-8. (Pubitemid 40779408)
12. Kato M, Kephart GM, Talley NJ, Wagner JM, Sarr MG, Bonno M, et al. Eosinophil infiltration and degranulation in normal human tissue. Anat Rec. 1998;252:418-25. (Pubitemid 28487881)
13. Straumann A, Bauer M, Fischer B, Blaser K, Simon HU. Idiopathic eosinophilic esophagitis is associated with a T-helper 2-type allergic inflammatory response. J Allergy Clin Immunol. 2001;108:954-61. (Pubitemid 33151548)
14. Fuentebella J, Patel A, Nguyen T, Sanjanwala B, Berquist W, Kerner JA, et al. Increased number of regulatory T cells in children with eosinophilic esophagitis. J Pediatr Gastroenterol Nutr. 2010;51:283-9.
15. Stuck MC, Straumann A, Simon HU. Relative lack of T regulatory cells in adult eosinophilic esophagitis - no normalization after corticosteroid therapy. Allergy. 2011;66:705-7.
16. Gonsalves N, Policarpio-Nicolas M, Zhang Q, Rao S, Hirano I. Histopathologic variability and endoscopic correlates in adults with eosinophilic esophagitis. Gastrointest Endoscopy. 2006;64:313-9. (Pubitemid 44233586)
17. Spechler SJ, Genta RM, Souza RF. Thoughts on the complex relationship between gastroesophageal reflux disease and eosinophilic esophagitis. Am J Gastroenterol. 2007;102:1301-6. (Pubitemid 46802025)
18. Locke GR III, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ III. Prevalence and clinical spectrum of gastroesophageal reflux: a populationbased study in Olmsted county, Minnesota. Gastroenterology. 1997;112:1448-56. (Pubitemid 27181367)
19. Molina-Infante J, Ferrando-Lamana L, Ripoll C, Hernandez-Alonso M, Mateos JM, Fernandez-Bermejo M, et al. Esophageal eosinophilic infiltration responds to proton pump inhibition in most adults. Clin Gastroenterol Hepatol. 2011;9:110-7.
20. Straumann A, Spichtin HP, Grize L, Bucher KA, Beglinger C, Simon HU, et al. Natural history of primary eosinophilic esophagitis: a follow-up of thirty patients for up to 11.5 years. Gastroenterology. 2003;125:1660-9. (Pubitemid 37500430)
21. Aceves SS, Newbury RO, Chen D, Mueller J, Dohil R, Hoffman H, et al. Resolution of remodeling in eosinophilic esophagitis correlates with epithelial response to topical corticosteroids. Allergy. 2010;65:109-16.
22. Mishra A, Wang M, Pemmaraju VR, Collins MH, Fulkerson PC, Abonia JP, et al. Esophageal remodeling develops as a consequence of tissue specific IL-5-induced eosinophilia. Gastroenterology. 2008;134:204-14. (Pubitemid 350309313)
23. Straumann A, Conus S, Degen L, Frei C, Bussmann C, Beglinger C, et al. Long-term budesonide maintenance treatment is partially effective for patients with eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2011;9:400-9.
24. Peterson KA, Thomas KL, Hilden K, Emerson LL, Wills JC, Fang JC. Comparison of esomeprazole to aerosolized swallowed fluticasone for eosinophilic oesophagitis. Dig Dis Sci. 2010;55:1313-9.
25. Faubion WA, Perrault J, Burgart LJ, Zein NN, Clawson ML, Freese DK. Treatment of eosinophilic esophagitis with inhaled corticosteroids. J Pediatr Gastroenterol Nutr. 1998;27:90-3. (Pubitemid 28293032)
26. Liacouras CA, Spergel JM, Ruchelli E, Verma R, Mascarenhas M, Semeao E, et al. Eosinophilic esophagitis: a 10-year experience in 381 children. Clin Gastroenterol Hepatol. 2005;3:1198-206. (Pubitemid 41797671)
27. Konikoff MR, Noel RJ. Blanchard C, Kirby C, Jameson SC, Buckmeier BK, et al. A randomized, double-blind, placebo-controlled trial of fluticasone propionate for pediatric eosinophilic esophagitis. Gastroenterology. 2006;131:1381-91. (Pubitemid 44780861)
28. Schaefer ET, Fitzgerald JF, Molleston JP, Croffie JM, Pfefferkorn MD, Corkins MR, et al. Comparison of oral prednisone and topical fluticasone in the treatment of eosinophilic esophagitis: A randomized trial in children. Clin Gastroenterol Hepatol. 2008;6:165-73. (Pubitemid 351172942)
29. Dohil R, Newbury R, Fox L, Bastian J, Aceves SS. Oral viscous budesonide is effective in children with eosinophilic esophagitis in a randomized, placebo-controlled trial. Gastroenterology. 2010;139:418-29.
30. Straumann A, Conus S, Degen L, Felder S, Kummer M, Engel H, et al. Budesonide is effective in adolescent and adult patients with active eosinophilic esophagitis. Gastroenterology. 2010;139:1526-37.
31. Attwood SE, Lewis CJ, Bronder CS, Morris CD, Armstrong GR, Whittam J. Eosinophilic oesophagitis: a novel treatment using Montelukast. Gut. 2003;52:181-5. (Pubitemid 36115056)
32. Lucendo AJ, De Rezende LC, Jimenez-Contreras S, Yagüe-Compadre JL, González-Cervera J, Mota-Huertas T, et al. Montelukast was inefficient in maintaining steroid-induced remission in adult eosinophilic esophagitis. Dig Dis Sci. 2011;56:3551-8.
33. Straumann A, Conus S, Grzonka P, Kita H, Kephart G, Bussmann C, et al. Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomized, placebo-controlled, double-blind trial. Gut. 2010;59:21-30.
34. Assa'ad AH, Gupta SK, Collins MH, Thomson M, Heath AT, Smith DA, Perschy TL, Jurgensen CH, Ortega HG, Aceves SS. An antibody against IL-5 reduces numbers of esophageal intraepithelial eosinophils in children with eosinophilic esophagitis. Gastroenterology. 2011;141:1593-604.
35. Straumann A, Bussmann C, Conus S, Beglinger C, Simon HU. Anti-TNF-alpha (infliximab) therapy for severe adult eosinophilic esophagitis. J Allergy Clin Immunol. 2008;122:425-7.
36. Netzer P, Gschossmann JM, Straumann A, Sendensky A, Weimann R, Schoepfer AM. Corticosteroid-dependent eosinophilic oesophagitis: azathioprine and 6-mercaptopurine can induce and maintain long-term remission. Eur J Gastroenterol Hepatol. 2007;19:865-9. (Pubitemid 47415145)
37. Markowitz JE, Spergel JM, Ruchelli E, Liacouras CA. Elemental diet is an effective treatment for eosinophilic esophagitis in children and adolescents. Am J Gastroenterol. 2003;98:777-82. (Pubitemid 36576301)
38. Kagalwalla AF, Sentongo TA, Ritz S, Hess T, Nelson SP, Emerick KM, et al. Effect of six-food elimination diet on clinical and histologic outcomes in eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2006;4:1097-102. (Pubitemid 44311644)
39. Gonsalves N, Ritz S, Yang G, Ditto A, Hirano I. A prospective clinical trial of allergy testing and food elimination diet in adults with eosinophilic esophagitis. Gastroenterology. 2007;132:A-6 (Abstract)
40. Schoepfer AM, Gonsalves N, Bussmann C, Conus S, Simon HU, Straumann A, et al. Esophageal dilation in eosinophilic esophagitis: effectiveness, safety, and impact on the underlying inflammation. Am J Gastroenterol. 2010;105:1062-70.
41. Dellon ES, Gibbs WB, Rubinas TC, Fritchie KJ, Madanick RD, Woosley JT, et al. Esophageal dilation in eosinophilic esophagitis: safety and predictors of clinical response and complications. Gastrointest Endosc. 2010;71:706-12.
42. Konikoff MR, Blanchard C, Kirby C, Buckmeier BK, Cohen MB, Heubi JE, et al. Potential of blood eosinophils, eosinophil-derived neurotoxin, and eotaxin-3 as biomarkers of eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2006;4:1328-36. (Pubitemid 44716743)